The Black Swan Research Initiative is a multi-sponsored research initiative. 

Pharmaceutical company supporters include:

Amgen, Inc.
Celgene Corporation
Bristol-Myers Squibb
Janssen Global Services, LLC
Karyopharm Therapeutics
The Binding Site, Inc.
The Takeda Oncology Company

Non-industry financial support includes:

More than twenty non-industry donors have supported the Black Swan Research Initiative with substantial gifts, many of which are multi-year. These donors include family foundations, corporations, member-event fundraisers, and personal gifts.